Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1235 | 952 | 1298 | 1780 | 3036 | 4678 |
Fund Return | 23.47% | -4.79% | 29.78% | 21.2% | 24.87% | 16.68% |
Place in category | 139 | 153 | 148 | 88 | 89 | 68 |
% in Category | 61 | 77 | 78 | 56 | 61 | 55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Tata Digital India Regular Growth | 126.59B | 29.50 | 12.31 | - | ||
INF277K01Z77 | 126.59B | 31.09 | 14.00 | - | ||
INF277K010S4 | 102.58B | 11.39 | 11.60 | - | ||
INF277K011O1 | 95.72B | 35.65 | 28.15 | - | ||
Tata Balanced Fund Direct PlanGr | 41.5B | 15.63 | 14.39 | 11.78 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HDFC MidCap Opportunities Div | 760.61B | 26.48 | 28.00 | 17.98 | ||
HDFC MidCap Opportunities Growth | 760.61B | 26.49 | 28.04 | 18.25 | ||
HDFC MidCap Opportunities Dir Div | 760.61B | 27.25 | 28.88 | 18.99 | ||
HDFC MidCap Opportunities Dir Gr | 760.61B | 27.26 | 28.92 | 19.22 | ||
Kotak Emerg Equity Scheme Direct Gr | 520.49B | 33.47 | 24.62 | 20.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Max Financial | INE180A01020 | 3.28 | 1,103.90 | +0.29% | |
Alkem Laboratories Ltd | INE540L01014 | 3.14 | 5,406.30 | -1.38% | |
Muthoot Finance | INE414G01012 | 2.99 | 2,035.00 | -1.57% | |
Cummins India Ltd | INE298A01020 | 2.87 | 3,377.20 | +0.50% | |
Aurobindo Pharma | INE406A01037 | 2.81 | 1,262.45 | +0.76% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review